TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Affinity DataKi: 0.282nMAssay Description:Adenosine A1 receptor binding using [3H]DPCPX in rat cortical membranesMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(RAT)
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Affinity DataKi: 0.490nMAssay Description:Adenosine A1 receptor binding using [3H]DPCPX in human cortical membranesMore data for this Ligand-Target Pair
Affinity DataKi: 0.490nMAssay Description:Adenosine A1 receptor binding using [3H]DPCOX in rat cortical membranesMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Affinity DataKi: 6.60nMAssay Description:Adenosine A1 receptor using [3H]DPCOX in rat cortical membranesMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 70nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 110nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
Affinity DataKi: 151nMAssay Description:Adenosine A2 receptor binding using [3H]CGS-21680 in rat striatal membranesMore data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 156nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 164nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 204nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 287nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(RAT)
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 440nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 500nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 550nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 750nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 970nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
Affinity DataKi: 1.20E+3nMAssay Description:Adenosine A2 receptor binding using [3H]CGS-21680 in rat striatal membranesMore data for this Ligand-Target Pair
Affinity DataKi: 1.26E+3nMAssay Description:Adenosine A2 receptor binding using [3H]CGS-21680 in rat striatal membranesMore data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 1.30E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 1.50E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 1.50E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 1.60E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 1.80E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 2.10E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 2.20E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 2.30E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 2.60E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School Of Medicine
Curated by ChEMBL
Vanderbilt University School Of Medicine
Curated by ChEMBL
Affinity DataKi: 4.90E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Fujisawa Pharmaceutical
Curated by PDSP Ki Database
Affinity DataIC50: 0.180nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.190nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.200nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.260nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.290nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.300nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.310nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.320nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.370nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.370nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.490nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.530nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.560nMAssay Description:Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)More data for this Ligand-Target Pair
Affinity DataIC50: 0.620nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair